Scopolamine (Ophthalmic)

Pregnancy Category: C

Lactation: Distributed in breast milk; American Academy of Pediatrics classifies scopolamine as compatible with breast-feeding

Pregnancy Categories

A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA:Information not available.

• If you have an allergy to scopolamine or any other part of scopolamine (ophthalmic).
• If you are allergic to any drugs like this one, any other drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.
• If you have glaucoma or a risk for glaucoma.

This is not a list of all drugs or health problems that interact with this medicine.

Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take scopolamine with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor.

If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened.

Hypersensitivity to scopolamine or any component of the formulation; narrow-angle glaucoma

Refer to adult dosing.

No dosage adjustment provided in manufacturer’s labeling.

Remove contact lenses prior to administration; wait 15 minutes before reinserting. To avoid excessive systemic absorption, finger pressure should be applied on the lacrimal sac for 2-3 minutes following application. Do not touch dropper to eye. Wash hands following administration.

Store at 8°C to 27°C (46°F to 80°F). Protect from light.

Intraocular pressure

Consult your pharmacist.